Incannex Healthcare Halted, News Pending
On Friday, Mizuho (NYSE:MFG) Securities adjusted its outlook on Globant S.A. (NYSE: GLOB), reducing the price target to $235 from the previous $247 while maintaining an Outperform rating on the stock. Currently trading at $210.17 with a market capitalization of $9.1 billion, the stock has seen a 4.8% decline over the past year. The revision follows the company’s fourth-quarter 2024 earnings report and the release of its initial 2025 guidance.
Globant’s guidance for 2025 organic constant currency (CC) growth of +9.5% did not meet the investors’ expectations of low double-digit growth. The underwhelming forecast was attributed to macroeconomic challenges in Latin America and a slower growth projection for Disney (NYSE:DIS), one of Globant’s key clients. According to InvestingPro, six analysts have recently revised their earnings estimates downward, though the company maintains a GOOD financial health score.Get deeper insights into Globant’s valuation and growth prospects with InvestingPro, which offers exclusive access to 10+ additional ProTips and comprehensive financial analysis.
Despite the cut in the price target, Mizuho’s stance on Globant remains positive. The firm believes that the company’s growth trajectory is promising and encourages investors to consider buying shares, especially if the stock price weakens. Two main reasons support their optimistic outlook: the anticipation of organic CC growth acceleration throughout the year as significant projects in the Middle East commence, and Globant’s competitive position with nearly +10% organic CC growth and an improving profitability forecast. The company has demonstrated strong performance with 15.26% revenue growth in the last twelve months, though it currently trades at a relatively high P/E ratio of 54x.
As a result of the updated guidance, Mizuho has also revised its revenue and earnings per share (EPS) estimates for Globant for the years 2025 and 2026. The new estimates reflect a more cautious outlook but still support the Outperform rating, signaling confidence in the company’s long-term potential despite near-term headwinds. Analysts expect EPS to reach $6.60 in FY2025, with price targets ranging from $140 to $270.
In other recent news, Globant S.A. reported its fourth-quarter earnings, showcasing an adjusted earnings per share (EPS) of $1.75, which exceeded analyst estimates of $1.73. Revenue for the quarter rose by 10.6% year-over-year to $642.5 million, slightly below the consensus forecast of $645.44 million. However, Globant’s guidance for 2025 disappointed Wall Street, with projections of adjusted EPS between $6.80 and $7.20 on revenue of $2.635 to $2.705 billion, falling short of analyst expectations of $7.34 EPS and $2.746 billion in revenue. This has led to a revised outlook from TD Cowen, which maintained a Buy rating but reduced the price target from $270 to $245, citing challenges in Latin America and changes in Disney programs. Similarly, JPMorgan lowered its price target for Globant from $248 to $242 while keeping an Overweight rating, noting that the company’s 2025 revenue outlook did not meet higher investor expectations. Despite these challenges, Globant’s management highlighted a record revenue achievement of $642.5 million for the quarter and expressed confidence in maintaining momentum into 2025. Investors, however, remain cautious due to the company’s revised growth trajectory and guidance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.